Trials
We are a biotechnology company that is dedicated to developing treatments for medical conditions that have the potential to change people’s lives. We see each clinical trial as a key milestone on this journey.
Patients are our North Star. We aim to develop innovative therapies focused on the health outcomes that matter most to patients by understanding their unique needs, priorities and perspectives. And we can only do that by engaging with them in trust-based, long-lasting and mutually beneficial partnerships, as outlined by our Patient Partnership Charter
Through the discovery of proteins that play a role in medical conditions, we can develop specific treatments that address the course of the medical condition itself, rather than just the symptoms. Hear about how this novel approach is used in practice and applied to medical conditions such as rheumatoid arthritis.
GL-NA-NA-202105-00001, May 2021
Understanding the true physical and emotional burden of medical conditions fuels our ambition to bring life-changing treatments to the people who need them most. To achieve this we use our innovative three-step approach.
We have ongoing clinical studies, including those in inflammation and fibrosis, taking place in six continents across the world.
If you are an investigator and interested in working with Galapagos, please contact us.
